Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets-Reference-Cited by-同舟云学术

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets

Published:2019-09-04 Issue: Volume:10 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

van de Wouw Jens,Broekhuizen Michelle,Sorop Oana,Joles Jaap A.,Verhaar Marianne C.,Duncker Dirk J.,Danser A. H. Jan,Merkus Daphne

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference197 articles.

1. How does proteinuria cause progressive renal damage?;Abbate;J. Am. Soc. Nephrol.,2006

2. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease;Agrawal;Nat. Rev. Cardiol.,2009

3. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study;Ahmed;Am. J. Cardiol.,2007

4. Fibroblast growth factor-23 and heart failure with reduced versus preserved ejection fraction: MESA;Almahmoud;J. Am. Heart Assoc.,2018

5. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia;Amann;Kidney Int.,2003

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of diastolic and renal dysfunctions in non-ST segment elevation acute coronary syndrome patients with heart failure with preserved ejection fraction and their impact on outcomes;Heart, Vessels and Transplantation;2024-09-08

2. The cold temperature associated with new-onset heart failure after incorporating dynamic status of multimorbidity: nationwide cohort, Taiwan 2012–2019;European Journal of Preventive Cardiology;2024-08-23

3. A nomogram for predicting the risk of heart failure with preserved ejection fraction;International Journal of Cardiology;2024-07

4. Effects of a medium cut‐off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure;Hemodialysis International;2024-06-25

5. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease;Journal of the American Heart Association;2024-06-18